theory on the mechanism of plasma exchange emphasizes the activating effects of this procedure. Activation of the body's own natural defense forces by plasma exchange has been demonstrated by deblocking of the splenic function (15) . This activation can be achieved by small volume exchange and persists even after the exchanges have been completed. As early as 1514, however, Brissot (1478-1522) was already arguing against activation (called «revulsion») and in favor of elimination (called «derivatio»).
The beneficial effect of activation can be explained only by the elimination of postulated blocking and other factors. Therefore, elimination is the prior and also the most universal effect of plasma exchange. Besides eliminating toxic drugs, hormones and other deleterious plasma components, plasma exchange removes immunological factors such as circulating anti-GBM antibodies, anti-ACh-receptor antibodies, pemphigus antibodies or circulating immunocomplexes, blocking factors to the reticulo-endothelial system or to antitumor leucocytes (6, (15) (16) (17) (18) . Not only are humoral immune mechanisms influenced by plasma exchange, but cellular immunity can also be stimulated or depressed, because chemotactic factors such as Iymphokines or cytokines are eliminated (19) . This effect on cellular immunity is better achieved by centrifugal procedures than by membrane plasma exchange, since leukapheresis can be performed. Thus, the effect of plasma exchange appears to be quite unspecific, and has been described as «blood is effectively washed» (20). This unselective and universal nature of the eliminative effect will possibly limit the usefulness of selectively removing a single pathogen by cascade filtration, cryofiltration, or immunoabsorption (21-23).
The elimination effect of plasma exchange has important clinical implications. To the extent that its beneficial effect is achieved by elimination rather than by activation, it depends on the intensity of plasma exchange; that is, elimination must supervene proliferation, which, in all diseases with an immunological basis, calls for concomitant immunosuppression. The intensity of plasma exchange, however, increases as the duration, 'lUmber, volume of exchanges, and treatment time increase. This means that intensity increases as costs and risks also increase. Intensity may be defined in terms of a reference substance such as IgM (900,000 dalton) usually not involved in the pathogenic mechanism and distributed exclusively in the plasma compartment. Standardization of intensity will be needed where membranes are used, especially reused ones. Elimination is a passive process. This allows a quantitative approach to plasma exchange using exponential functions (8, (24) (25) (26) . The kinetics of exponential functions have been applied successfully in both clinical pharmacokinetics and hemodialysis planning (27). Standardization and quantita-
